Inactive Instrument
US Rare Earth Minerals Inc Stock Other OTC
Stocks
US9034101082
Biotechnology & Medical Research
OTC Markets Traded|
End-of-day quote
Other stock markets
|
||
| - USD | - |
|
| 05-15 | Bioxytran, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
| 04-15 | Bioxytran, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 | CI |
| Market Cap | 3.17M 2.74M 2.53M 2.37M 4.43M 302M 4.5M 29.83M 11.63M 147M 11.91M 11.66M 509M | P/E Ratio 2024 |
-5.27x | P/E Ratio 2025 | -3.28x |
|---|---|---|---|---|---|
| Enterprise Value | 3.92M 3.38M 3.12M 2.92M 5.47M 372M 5.55M 36.8M 14.35M 181M 14.69M 14.38M 627M | EV / Sales 2024 |
-
| EV / Sales 2025 | - |
| Free-Float |
99.38% | Yield 2024 * |
-
| Yield 2025 | - |
| Manager | Title | Age | Since |
|---|---|---|---|
David Platt
CEO | Chief Executive Officer | 73 | 2018-08-31 |
Ola Soderquist
DFI | Director of Finance/CFO | 65 | 2018-08-31 |
Leslie Ajayi
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Dale Conaway
BRD | Director/Board Member | 71 | 2018-11-01 |
Alan Hoberman
BRD | Director/Board Member | 73 | 2018-11-01 |
David Platt
CHM | Chairman | 73 | 2018-08-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.86% | -0.26% | +57.57% | +110.98% | 56.42B | |
| -0.34% | +2.91% | +45.55% | +46.87% | 44.54B | |
| +1.31% | +7.43% | -13.62% | -18.72% | 22.9B | |
| +1.16% | +4.95% | -2.71% | +393.93% | 21.21B | |
| -0.51% | -5.56% | +10.43% | -29.97% | 16.4B | |
| -1.54% | -1.06% | +8.10% | -39.28% | 15.4B | |
| -0.20% | +2.03% | +26.44% | +176.39% | 13.35B | |
| +0.96% | +6.56% | +20.81% | - | 12.36B | |
| +0.32% | +1.60% | +96.37% | +207.56% | 11.15B | |
| Average | -0.17% | +1.66% | +27.66% | +105.97% | 23.75B | |
| Weighted average by Cap. | -0.65% | +2.54% | +32.23% | +98.57% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | - | - |
| Net income | -2.37M -2.04M -1.88M -1.76M -3.3M -225M -3.36M -22.24M -8.67M -109M -8.88M -8.69M -379M | -2.12M -1.83M -1.69M -1.58M -2.96M -202M -3.01M -19.95M -7.78M -98.22M -7.97M -7.8M -340M |
| Net Debt | 1.09M 941K 867K 811K 1.52M 104M 1.54M 10.23M 3.99M 50.38M 4.09M 4M 174M | 741K 640K 590K 552K 1.03M 70.41M 1.05M 6.96M 2.71M 34.27M 2.78M 2.72M 119M |
Employees
-
Select your edition
All financial news and data tailored to specific country editions
